Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Vivian Shi to Antibodies, Monoclonal, Humanized

This is a "connection" page, showing publications Vivian Shi has written about Antibodies, Monoclonal, Humanized.

 
Connection Strength
  
 
 
5.108
  
  1. Carnicle JM, Hendricks AJ, Shi VY. Reactivation of Alopecia Areata After Dupilumab Therapy for Atopic Dermatitis. Dermatitis. 2021 Oct 01; 32(1S):e80-e82.
    View in: PubMed
    Score: 0.702
  2. Ludwig CM, Hsiao JL, Lio PA, Shi VY. Transitioning From Immunosuppressants to Dupilumab in Pediatric Atopic Dermatitis. Dermatitis. 2021 Oct 01; 32(1S):S4-S7.
    View in: PubMed
    Score: 0.702
  3. Hendricks AJ, Yosipovitch G, Shi VY. Dupilumab use in dermatologic conditions beyond atopic dermatitis - a systematic review. J Dermatolog Treat. 2021 Feb; 32(1):19-28.
    View in: PubMed
    Score: 0.616
  4. Hendricks AJ, Lio PA, Shi VY. Management Recommendations for Dupilumab Partial and Non-durable Responders in Atopic Dermatitis. Am J Clin Dermatol. 2019 Aug; 20(4):565-569.
    View in: PubMed
    Score: 0.604
  5. Heibel HD, Hendricks AJ, Foshee JP, Shi VY. Rosacea associated with dupilumab therapy. J Dermatolog Treat. 2021 Feb; 32(1):114-116.
    View in: PubMed
    Score: 0.598
  6. Hendricks AJ, Lio PA, Shi VY. Dupilumab and Alopecia: Causative or Therapeutic? Dermatology. 2019; 235(4):306-307.
    View in: PubMed
    Score: 0.592
  7. Shi VY, Bhutani T, Fonacier L, Deleuran M, Shumack S, Valdez H, Zhang F, Chan GL, Cameron MC, Yin NC. Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND). J Am Acad Dermatol. 2022 08; 87(2):351-358.
    View in: PubMed
    Score: 0.182
  8. Thompson AM, Yu L, Hsiao JL, Shi VY. Dermatology-ophthalmology collaborations are needed in dupilumab-associated ocular events. J Am Acad Dermatol. 2021 06; 84(6):e279-e280.
    View in: PubMed
    Score: 0.167
  9. Ludwig CM, Krase JM, Shi VY. T Helper 2 Inhibitors in Allergic Contact Dermatitis. Dermatitis. 2021 Jan-Feb 01; 32(1):15-18.
    View in: PubMed
    Score: 0.167
  10. Hwang J, Jaros J, Shi VY. Staphylococcus aureus in Atopic Dermatitis: Past, Present, and Future. Dermatitis. 2020 Jul/Aug; 31(4):247-258.
    View in: PubMed
    Score: 0.161
  11. Jaros J, Hendricks AJ, Shi VY, Lio PA. A Practical Approach to Recalcitrant Face and Neck Dermatitis in Atopic Dermatitis. Dermatitis. 2020 May-Jun; 31(3):169-177.
    View in: PubMed
    Score: 0.159
  12. Ludwig CM, Krase JM, Price KN, Lio PA, Shi VY. A practical guide for transitioning from classical immunosuppressants to dupilumab in atopic dermatitis. J Dermatolog Treat. 2021 Aug; 32(5):503-506.
    View in: PubMed
    Score: 0.154
  13. Berman HS, Villa NM, Shi VY, Hsiao JL. Guselkumab in the treatment of concomitant hidradenitis suppurativa, psoriasis, and Crohn's disease. J Dermatolog Treat. 2021 Mar; 32(2):261-263.
    View in: PubMed
    Score: 0.152
  14. Hendricks AJ, Shi VY. Learning About Dupilumab-Associated Conjunctivitis. JAMA Dermatol. 2019 06 01; 155(6):754.
    View in: PubMed
    Score: 0.149
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.